Although direct interaction of EpCAM, CD44 variants, and claudin-7 was not examined in our study, the results suggest that complexes of EpCAM with CD44 variants and claudin-7 may be associated with the aggressive phenotype of anaplastic thyroid cancer. This evidence concerns the gene CD44 and thyroid gland undifferentiated (anaplastic) carcinoma.